A carregar...
Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies
Chimeric antigen receptor T cells (CAR-Ts) constitute a novel therapeutic strategy for relapsed/refractory B-cell malignancies. With the extensive application of CAR-T therapy in clinical settings, CAR-T-associated toxicities have become increasingly apparent. However, information regarding the asso...
Na minha lista:
| Publicado no: | Cell Transplant |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216343/ https://ncbi.nlm.nih.gov/pubmed/34144648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/09636897211025503 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|